0001661460-18-000001.txt : 20180403 0001661460-18-000001.hdr.sgml : 20180403 20180403152451 ACCESSION NUMBER: 0001661460-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180403 DATE AS OF CHANGE: 20180403 EFFECTIVENESS DATE: 20180403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Poseida Therapeutics, Inc. CENTRAL INDEX KEY: 0001661460 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-309225 FILM NUMBER: 18733033 BUSINESS ADDRESS: STREET 1: 4250 EXECUTIVE SQUARE, SUITE 900 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-242-1576 MAIL ADDRESS: STREET 1: 4250 EXECUTIVE SQUARE, SUITE 900 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001661460 Poseida Therapeutics, Inc. 4242 Campus Point Court, Suite 700 San Diego CA CALIFORNIA 92121 858-779-3100 DELAWARE None None Corporation true 2014 Eric Ostertag 4242 Campus Point Court, Suite 700 San Diego CA CALIFORNIA 92121 Executive Officer Director Mark Gergen 4242 Campus Point Court, Suite 700 San Diego CA CALIFORNIA 92121 Executive Officer Director Adrian Howd 4242 Campus Point Court, Suite 700 San Diego CA CALIFORNIA 92121 Director David Hirsch 4242 Campus Point Court, Suite 700 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2018-03-19 false true false 0 30499990 30499990 0 false 7 0 0 0 false Poseida Therapeutics, Inc. Eric Ostertag Eric Ostertag President and CEO 2018-04-03